Matt is a leader in PwC’s Strategic Technologies practice and takes an innovation-led approach to his clients when delivering their strategic technology transformation initiatives. His 18+ years working at the intersection of technology and pharma R&D have provided his clients with pragmatic technology solutions to improve the way medicines are discovered and developed.
Matt is a champion for the evolution of pharma R&D organizations’ move from established to emerging technologies. He is working with this clients to benefit from the significant impact this move has had on the business and IT teams across their relationships, productivity and scientific advancement. Specifically, Matt has led scientific and operational analytics initiatives as well as implemented digital technologies within the Clinical Development, Regulatory Operations and Pharmacovigilance areas.
Matt holds a Bachelor’s of Science degrees in Chemical Engineering and Management of Technology from the University of Minnesota.
Tuesday, September 24
1:00 PM – 1:55 PM